Valuation
- Market cap
- 5,177,000
- Revenue TTM
- $2,130,000
- Net income TTM
- $-62,010,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -2,911.27%
- Debt to equity
- 0.00
Trading
- Volume
- 59,300
- Avg volume
- 1,974
- Day's range
- $2.80 – $2.84
- Shares out
- 1,823,000
- Stochastic %K
- 100%
- Beta
- 1.32
- Analysts
- —
- Price target
- $5.00
Company profile
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other stra...
Show more
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 650-433-3000
- Website
- https://talisbio.com
- Address
- 1375 West Fulton Market, Suite 700, Chicago, United States
Latest news
No headlines yet.
